BIO-TECHNE Corp — Director's Dealing 2023

Apr 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2023-04-03

Reporting Person: Bohnen Shane (SVP - General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-03	Restricted Stock Units	$	A	6778	Acquired		Common Stock (6778)	Direct
2023-04-03	Stock Option (right to buy)	$73.76	A	3928	Acquired	2033-04-03	Common Stock (3928)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F2: 2,259 shares vest on 4/3/24, 2,260 shares vest on 4/3/25 and 2,259 shares vest on 4/3/26.

F3: Options to purchase 982 shares vest on each of 4/3/24, 4/3/25, 4/3/26 and 4/3/27.